Close Menu

This article has been updated to correct Thermo Fisher Scientific's stake in Yourgene Health and to provide additional information about previous loan agreements.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific has acquired a 9 percent stake in molecular diagnostic company Yourgene Health by exercising warrants it held in the company.

In addition, Thermo Fisher has further warrants that, if exercised, could take its ownership to 17 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
13

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
17

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.